CROWLEY Richard 4
4 · SAVIENT PHARMACEUTICALS INC · Filed Feb 4, 2013
Insider Transaction Report
Form 4
CROWLEY Richard
EVP Biopharmaceutical Operatio
Transactions
- Sale
Common Stock $.01 par value per share
2013-01-31$1.02/sh−2,415$2,463→ 336,875 total
Footnotes (1)
- [F1]These share were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax witholding obligations in connection with the vesting of restricted stock granted on May 24, 2011